Literature DB >> 32512638

Effects of electroporation treatment using different concentrations of Cas9 protein with gRNA targeting Myostatin (MSTN) genes on the development and gene editing of porcine zygotes.

Quynh A Le1, Maki Hirata1, Nhien T Nguyen1, Koki Takebayashi1, Manita Wittayarat2, Yoko Sato3, Zhao Namula4, Masahiro Nii5, Fuminori Tanihara1, Takeshige Otoi1.   

Abstract

This study was conducted to investigate the effect of seven concentrations of Cas9 protein (0, 25, 50, 100, 200, 500, and 1,000 ng/µl) on the development and gene editing of porcine embryos. This included the target editing and off-target effect of embryos developed from zygotes that were edited via electroporation of the Cas9 protein with guide RNA targeting Myostatin genes. We found that the development to blastocysts of electroporated zygotes was not affected by the concentration of Cas9 protein. Although the editing rate, which was defined as the ratio of edited blastocysts to total examined blastocysts, did not differ with Cas9 protein concentration, the editing efficiency, which was defined as the frequency of indel mutations in each edited blastocyst, was significantly decreased in the edited blastocysts from zygotes electroporated with 25 ng/µl of Cas9 protein compared with that of blastocysts from zygotes electroporated with higher Cas9 protein concentrations. Moreover the frequency of indel events at the two possible off-target sites was not significantly different with different concentrations of Cas9 protein. These results indicate that the concentration of Cas9 protein affects gene editing efficiency in embryos but not the embryonic development, gene editing rate, and non-specific cleavage of off-target sites.
© 2020 Japanese Society of Animal Science.

Entities:  

Keywords:  Cas9 protein; blastocysts; electroporation; gene editing; porcine embryos

Year:  2020        PMID: 32512638     DOI: 10.1111/asj.13386

Source DB:  PubMed          Journal:  Anim Sci J        ISSN: 1344-3941            Impact factor:   1.749


  7 in total

1.  One-Step Generation of Multiple Gene-Edited Pigs by Electroporation of the CRISPR/Cas9 System into Zygotes to Reduce Xenoantigen Biosynthesis.

Authors:  Fuminori Tanihara; Maki Hirata; Nhien Thi Nguyen; Osamu Sawamoto; Takeshi Kikuchi; Takeshige Otoi
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

2.  Comparison of the effects of introducing the CRISPR/Cas9 system by microinjection and electroporation into porcine embryos at different stages.

Authors:  Quynh Anh Le; Fuminori Tanihara; Manita Wittayarat; Zhao Namula; Yoko Sato; Qingyi Lin; Koki Takebayashi; Maki Hirata; Takeshige Otoi
Journal:  BMC Res Notes       Date:  2021-01-06

3.  Zona pellucida treatment before CRISPR/Cas9-mediated genome editing of porcine zygotes.

Authors:  Zhao Namula; Maki Hirata; Quynh Anh Le; Qingyi Lin; Koki Takebayashi; Naoaki Yoshimura; Fuminori Tanihara; Chommanart Thongkittidilok; Takeshige Otoi
Journal:  Vet Med Sci       Date:  2021-10-21

4.  Generation of mutant pigs by lipofection-mediated genome editing in embryos.

Authors:  Maki Hirata; Manita Wittayarat; Zhao Namula; Quynh Anh Le; Qingyi Lin; Koki Takebayashi; Chommanart Thongkittidilok; Taro Mito; Sayuri Tomonari; Fuminori Tanihara; Takeshige Otoi
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

5.  Triple gene editing in porcine embryos using electroporation alone or in combination with microinjection.

Authors:  Zhao Namula; Quynh Anh Le; Manita Wittayarat; Qingyi Lin; Koki Takebayashi; Maki Hirata; Lanh Thi Kim Do; Fuminori Tanihara; Takeshige Otoi
Journal:  Vet World       Date:  2022-02-27

Review 6.  Current status of the application of gene editing in pigs.

Authors:  Fuminori Tanihara; Maki Hirata; Takeshige Otoi
Journal:  J Reprod Dev       Date:  2021-04-10       Impact factor: 2.214

7.  Efficient generation of GGTA1-deficient pigs by electroporation of the CRISPR/Cas9 system into in vitro-fertilized zygotes.

Authors:  Fuminori Tanihara; Maki Hirata; Nhien Thi Nguyen; Osamu Sawamoto; Takeshi Kikuchi; Masako Doi; Takeshige Otoi
Journal:  BMC Biotechnol       Date:  2020-08-18       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.